Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crohn Disease | 6 | 2022 | 767 | 0.550 |
Why?
|
| Inflammatory Bowel Diseases | 6 | 2022 | 605 | 0.540 |
Why?
|
| Gastrointestinal Diseases | 2 | 2003 | 151 | 0.350 |
Why?
|
| Nutritional Status | 2 | 2003 | 82 | 0.240 |
Why?
|
| Colitis, Ulcerative | 3 | 2022 | 765 | 0.230 |
Why?
|
| Child | 14 | 2022 | 7273 | 0.230 |
Why?
|
| Growth | 1 | 2003 | 43 | 0.210 |
Why?
|
| Child Nutrition Disorders | 1 | 2003 | 12 | 0.210 |
Why?
|
| Health Services | 1 | 2003 | 56 | 0.210 |
Why?
|
| Gastroenterology | 1 | 2003 | 151 | 0.180 |
Why?
|
| Growth Disorders | 1 | 2020 | 63 | 0.180 |
Why?
|
| Body Height | 1 | 2020 | 101 | 0.170 |
Why?
|
| Eosinophilia | 1 | 2001 | 85 | 0.170 |
Why?
|
| Severity of Illness Index | 4 | 2019 | 1892 | 0.170 |
Why?
|
| Abdominal Pain | 1 | 2001 | 142 | 0.160 |
Why?
|
| Child Development | 1 | 2021 | 167 | 0.160 |
Why?
|
| Sex Characteristics | 1 | 2021 | 329 | 0.160 |
Why?
|
| Adolescent | 11 | 2021 | 9411 | 0.150 |
Why?
|
| Patient Care | 1 | 2019 | 101 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2019 | 108 | 0.150 |
Why?
|
| Immunologic Factors | 1 | 2019 | 172 | 0.150 |
Why?
|
| Child, Preschool | 6 | 2021 | 3790 | 0.140 |
Why?
|
| Phenobarbital | 1 | 1997 | 33 | 0.140 |
Why?
|
| Sex Factors | 1 | 2020 | 1082 | 0.140 |
Why?
|
| Adenoma, Liver Cell | 1 | 1996 | 3 | 0.140 |
Why?
|
| Bone Density | 1 | 1998 | 214 | 0.140 |
Why?
|
| Periodicity | 1 | 1997 | 119 | 0.130 |
Why?
|
| Hypnotics and Sedatives | 1 | 1997 | 132 | 0.130 |
Why?
|
| Milk Proteins | 1 | 2016 | 24 | 0.130 |
Why?
|
| Infant Formula | 1 | 2016 | 17 | 0.130 |
Why?
|
| Mass Screening | 1 | 2020 | 646 | 0.130 |
Why?
|
| Milk Hypersensitivity | 1 | 2016 | 10 | 0.130 |
Why?
|
| Celiac Disease | 1 | 2019 | 215 | 0.130 |
Why?
|
| Vomiting | 1 | 1997 | 198 | 0.120 |
Why?
|
| Problem Solving | 1 | 2015 | 54 | 0.120 |
Why?
|
| Gastritis | 1 | 2015 | 36 | 0.120 |
Why?
|
| Fever | 1 | 2015 | 127 | 0.120 |
Why?
|
| Medication Adherence | 1 | 2015 | 141 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 608 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2015 | 185 | 0.110 |
Why?
|
| Infant, Premature | 1 | 2016 | 299 | 0.110 |
Why?
|
| Chronic Disease | 3 | 2019 | 960 | 0.110 |
Why?
|
| Inflammation | 1 | 2019 | 998 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2015 | 241 | 0.100 |
Why?
|
| Blood Sedimentation | 1 | 2012 | 13 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 3 | 2019 | 1404 | 0.100 |
Why?
|
| Menarche | 2 | 2022 | 30 | 0.100 |
Why?
|
| Female | 13 | 2022 | 47186 | 0.100 |
Why?
|
| Thalidomide | 1 | 2012 | 56 | 0.100 |
Why?
|
| Fistula | 1 | 2012 | 42 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2012 | 349 | 0.090 |
Why?
|
| Prednisone | 1 | 2012 | 255 | 0.090 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2010 | 1 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2375 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 1996 | 763 | 0.080 |
Why?
|
| Male | 12 | 2021 | 43249 | 0.080 |
Why?
|
| Humans | 18 | 2022 | 91074 | 0.080 |
Why?
|
| Intestines | 1 | 2012 | 419 | 0.080 |
Why?
|
| Colitis | 1 | 2010 | 251 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 3716 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1093 | 0.070 |
Why?
|
| Quality of Life | 1 | 2015 | 1699 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2021 | 4367 | 0.070 |
Why?
|
| Hospitalization | 1 | 2012 | 903 | 0.060 |
Why?
|
| Infant | 2 | 2016 | 3204 | 0.050 |
Why?
|
| Anthropometry | 1 | 2003 | 75 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2015 | 8436 | 0.050 |
Why?
|
| Biopsy | 2 | 2015 | 1196 | 0.050 |
Why?
|
| Thioguanine | 1 | 2001 | 17 | 0.050 |
Why?
|
| Mercaptopurine | 1 | 2001 | 53 | 0.050 |
Why?
|
| Age Determination by Skeleton | 1 | 2020 | 12 | 0.050 |
Why?
|
| Puberty, Delayed | 1 | 2020 | 19 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2016 | 2510 | 0.040 |
Why?
|
| Infliximab | 2 | 2012 | 159 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2001 | 233 | 0.040 |
Why?
|
| Jews | 1 | 2019 | 42 | 0.040 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2019 | 18 | 0.040 |
Why?
|
| Butyrophilins | 1 | 2019 | 25 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2019 | 83 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2015 | 988 | 0.040 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 1998 | 12 | 0.040 |
Why?
|
| Diet, Gluten-Free | 1 | 2019 | 58 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 323 | 0.040 |
Why?
|
| Radius | 1 | 1998 | 31 | 0.040 |
Why?
|
| Glutens | 1 | 2019 | 84 | 0.040 |
Why?
|
| Puberty | 1 | 1998 | 60 | 0.040 |
Why?
|
| Antigens | 1 | 2019 | 229 | 0.040 |
Why?
|
| Hormones | 1 | 1998 | 139 | 0.040 |
Why?
|
| Pedigree | 1 | 2019 | 970 | 0.030 |
Why?
|
| Migraine Disorders | 1 | 1997 | 40 | 0.030 |
Why?
|
| Reference Values | 1 | 1998 | 662 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 660 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 410 | 0.030 |
Why?
|
| Protein Hydrolysates | 1 | 2016 | 9 | 0.030 |
Why?
|
| Liver | 2 | 2001 | 1222 | 0.030 |
Why?
|
| Milk | 1 | 2016 | 53 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 2016 | 62 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 2711 | 0.030 |
Why?
|
| Birth Weight | 1 | 2016 | 147 | 0.030 |
Why?
|
| Enteral Nutrition | 1 | 2016 | 105 | 0.030 |
Why?
|
| Cattle | 1 | 2016 | 379 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1265 | 0.030 |
Why?
|
| Amino Acids | 1 | 2016 | 250 | 0.030 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2016 | 80 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2015 | 163 | 0.030 |
Why?
|
| Recurrence | 1 | 1997 | 1170 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2015 | 673 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 809 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 2015 | 174 | 0.030 |
Why?
|
| Calcium | 1 | 1998 | 1182 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2016 | 9400 | 0.030 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2012 | 63 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1609 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 3825 | 0.020 |
Why?
|
| Adalimumab | 1 | 2012 | 89 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 222 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2012 | 91 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 803 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 5608 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 2682 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 1493 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 6502 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 968 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 27147 | 0.010 |
Why?
|
| Leukopenia | 1 | 2001 | 67 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2001 | 224 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2002 | 371 | 0.010 |
Why?
|
| Azathioprine | 1 | 2001 | 124 | 0.010 |
Why?
|
| Animals | 2 | 2016 | 27783 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2001 | 255 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 26555 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2001 | 681 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2001 | 1753 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 2416 | 0.010 |
Why?
|
| Mice | 1 | 2002 | 11993 | 0.000 |
Why?
|